Received Jan 20, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5J959 | — |
POTENTIAL ERROR COULD HAVE BEEN MADE WHERE PATIENT DID NOT RECEIVE THE COMBINATION OF THE ADJUVANT AND ANTIGEN. AFTER ANALYIS MADE BY RISK MANAGEMENT AND PER RECOMMENDATIONS OF INFECTIOUS DISEASE MEDICAL DOCTOR, PATIENT WILL BE OFFERED REPEAT DOSE.